China Universal Asset Management »

Candel Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $51k 8.9k 5.65
2022-09-30 $999 271 3.69

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Proshares Ultra Gold Etp (UGL)
Netflix Common Stock (NFLX)
Spdr Gold Minishares Trust Etp (GLDM)

View all positions for China Universal Asset Management

Top funds holding Candel Therapeutics

FMR
BlackRock
Acorn Capital Advisors
Vanguard Group
Portolan Capital Management
Geode Capital Management
State Street Corporation
Halter Ferguson Financial
Citadel Advisors
Sands Capital Ventures
Northern Trust
Susquehanna International
Tanager Wealth Management
Jane Street
Wellington Management Company

View all funds holding Candel Therapeutics